Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody–Drug Radioconjugate
Laura Bannister, Sarah Frye, Randy Perron, Candice Didychuk et al.
Citations
10 citations
Journal
Clinical Cancer Research
Topics
Radiopharmaceutical Chemistry and Applications
Field-Weighted Citation Impact (FWCI)
4.04
article
Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody–Drug Radioconjugate
Laura Bannister, Sarah Frye, Randy Perron, Candice Didychuk, Anjong Florence Tikum, Fabrice Ngoh Njotu, Jessica Pougoue Ketchemen, Emmanuel Nwangele, Humphrey Fonge, Hanan Babeker, Alissar Monzer, Chris Byrne, Qi Qi, Nikita Henning, Alireza Doroudi, Nava Hassani
article en
10 citations
Abstract
No abstract available for this paper.
Publication Tag
Clinical Cancer ResearchVol. 31(4)
Institutions
Royal University Hospital (CA), University of Saskatchewan (CA), Canadian Nuclear Laboratories (CA), Saskatoon Medical Imaging (CA), Hôtel-Dieu de Québec (CA), Centre hospitalier de l'Université Laval (CA), Université Laval (CA), Canadian Nuclear Laboratories (CA)